MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Arm Swing and Early Gait Characteristics in Parkinson’s Disease

    C. Aaen, M. Vendelhaven, A. Behrndtz, M. Stilund, A. Terkelsen, E. Danielsen, E. Johnsen, M. Møller, W. Sloth, J. Brincks, J. Phan (Horsens, Denmark)

    Objective: This study aims to develop algorithms that quantify gait parameters reflecting early clinical gait changes in PD. Background: Parkinson’s disease (PD) is the fastest growing neurological…
  • 2026 International Congress

    Auricular Symptoms in Cervical Dystonia: A Case Series

    H. Ooi, H. Sarva, P. Garcia-Ruiz, E. Gatto (New York, USA)

    Objective: To describe 3 cases of cervical dystonia with ear symptoms Background: Dystonia is a movement disorder defined by sustained, patterned, sometimes tremulous postures with…
  • 2026 International Congress

    Movement Disorders Associated with Infections in Immunocompromised Non-HIV Patients: A Systematic Review

    J. Sánchez-León, M. Parra Alvarez, I. Da-Silva-Gomes, T. Schlickmann, T. Luise Denicol, C. Matte Dagostini, D. Teixeira-Dos-Santos, A. Schumacher Schuh (Porto Alegre, Brazil)

    Objective: To identify the most frequent movement disorders and their clinical features, as well as the most common infectious etiologies in immunocompromised non-HIV patients, based…
  • 2026 International Congress

    Integrating Olink Proteomics and Multimodal MRI to Reveal a Multimodal Signature of Parkinson’s Disease with REM Sleep Behavior Disorder

    LH. Zhu, F. Wang, YY. Zhu, KF. Yin, CX. Liu, LF. Yang, Q. Cui, WN. Xiong, YB. Han, AL. Pang, XL. Yang (kunming, China)

    Objective: To define the distinct multimodal biomarker profile of Parkinson’s disease with rapid eye movement sleep behavior disorder (PD-RBD) by integrating clinical data, Olink-based plasma…
  • 2026 International Congress

    SNCA-Targeting RNAi Therapeutics Prevent Disease Progression in a Synucleinopathy Mouse Model and Enable Robust, Prolonged, and Safe Alpha-Synuclein Protein Reduction in the Cynomolgus Monkey Central Nervous System

    P. Aimé-Wilson, N. Keating, C. Galligan, C. Brown, M. Gao, P. Mookherjee, S. Godin, J. Dave, M. Retter, A. Castoreno, K. Brown, M. Ahmed, A. Avbersek, C. Kyratsous (Tarrytown, USA)

    Objective: Assess the nonclinical efficacy and safety of C16-conjugated siRNAs targeting SNCA mRNA (SNCA siRNA). Background: Parkinson’s disease is a neurodegenerative disorder with an estimated…
  • 2026 International Congress

    Late onset chorea secondary to antiphospholipid syndrome with radiological correlation on brain FDG-PET: a case report.

    A. Bonilla Tena, G. Lafuente Gómez, A. Contreras Chicote, B. Casa Fages, J. Pérez Sánchez, E. Luque Buzo, V. Pérez Olmo, F. Grandas Pérez (Madrid, Spain)

    Objective: To describe chorea as the initial manifestation of antiphospholipid syndrome (APS) and its radiological correlation on brain FDG-PET as an autoimmune movement disorder. Background:…
  • 2026 International Congress

    Neuropsychiatric Symptom Changes in Parkinson’s Disease Patients Treated with Different Doses of Donepezil: A 24-Week Follow-up Study

    EJ. Chung (Busan, Republic of Korea)

    Objective: This study analyzed the effectiveness of donepezil therapy on neuropsychiatric symptoms in Parkinson’s disease with cognitive impairment (PD-CI), depending on the dose administered. Background:…
  • 2026 International Congress

    Recruitment Strategies in a Diverse Parkinson’s Disease Cohort: Lessons from the East London Parkinson’s Disease Project

    KC. Dey, E. Bhadra, A. Zirra, E. Camboe, V. Azoidou, D. Gallagher, T. Boyle, C. Budu, S. Hussain-Ali, CR. Marshall, LJ. Smith, AJ. Noyce (London, United Kingdom)

    Objective: To describe and evaluate recruitment strategies implemented in the East London Parkinson’s Disease (ELPD) Project that were designed to enhance engagement and participation among diverse communities in…
  • 2026 International Congress

    Speech Changes as Biomarkers in Huntington’s Disease: a Meta-Analysis

    D. Nguyen, S. Yan, M. Elias, Y. Altun (Bronx, USA)

    Objective: To perform a meta-analysis evaluating acoustic speech features as potential biomarkers of Huntington’s disease by comparing individuals with manifest HD and premanifest HD to…
  • 2026 International Congress

    A National Interprofessional Model for Parkinson’s Disease Education: Over 20 Years of Collaborative Learning Across the Veterans Health Administration

    E. Wong, A. Li Wong, G. Glenn (San Francisco, USA)

    Objective: To describe a national interprofessional education model for Parkinson's disease across the Veterans Health Administration. Background: In 2000, Congress urged the VHA to establish…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley